1. Home
  2. FEAM vs PYPD Comparison

FEAM vs PYPD Comparison

Compare FEAM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$1.51

Market Cap

81.4M

Sector

Industrials

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.12

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
PYPD
Founded
2016
2008
Country
United States
Israel
Employees
35
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
81.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FEAM
PYPD
Price
$1.51
$4.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$6.38
$12.00
AVG Volume (30 Days)
207.9K
53.2K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$2.33
52 Week High
$7.50
$5.12

Technical Indicators

Market Signals
Indicator
FEAM
PYPD
Relative Strength Index (RSI) 43.18 42.62
Support Level $1.17 $3.13
Resistance Level $2.16 $4.38
Average True Range (ATR) 0.17 0.20
MACD 0.03 -0.00
Stochastic Oscillator 51.80 16.98

Price Performance

Historical Comparison
FEAM
PYPD

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: